BioMEL: a translational research biobank of melanocytic lesions and melanoma
Introduction Diagnosing invasive cutaneous melanoma (CM) can be challenging due to subjectivity in distinguishing equivocal nevi, melanoma in situ and thin CMs. The underlying molecular mechanisms of progression from nevus to melanoma must be better understood. Identifying biomarkers for treatment r...
Main Authors: | Göran Jönsson, Ana Carneiro, Katja Harbst, Christian Ingvar, Teo Helkkula, Gustav Christensen, Karolin Isaksson, Bertil Persson, Åsa Ingvar, Anna Hafström, Viktoria Gaspar, Kari Nielsen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-02-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/14/2/e069694.full |
Similar Items
-
Acral Melanoma Incidence and Survival Trends in 1990–2020: A Nationwide, Population-based Study
by: Teo Helkkula, et al.
Published: (2024-08-01) -
Participation in a Prospective Cohort Study on Melanoma did not Affect the Incidence and Mortality of the Studied Disease
by: Åsa M. Ingvar, et al.
Published: (2020-01-01) -
DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype
by: Adriana Sanna, et al.
Published: (2022-10-01) -
Factors for not performing total body skin examinations in primary care in association with teledermoscopy
by: Jonas Ingvar, et al.
Published: (2023-03-01) -
Molecular patterns of resistance to immune checkpoint blockade in melanoma
by: Martin Lauss, et al.
Published: (2024-04-01)